Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Subsequent Offering Period For Aventis Expires

By Pharmaceutical Processing | September 7, 2004

PARIS, (Sept. 7, 2004) – Sanofi-Aventis said that the subsequent offering period in its French, German and United States offers for Aventis expired simultaneously on September 6 at 5 p.m. (Eastern).

Accordingly, holders of Aventis ordinary shares and ADSs may no longer tender into the offers and may not withdraw Aventis ordinary shares and ADSs that have already been tendered, the company said.

Sanofi-Aventis expects that the French Autorite des marchis financiers (AMF) will publish the definitive final results of the offers on September 16. Sanofi-Aventis intends to issue a press release regarding the definitive final results of the offers promptly after the announcement by the AMF.

In accordance with the requirements of the New York Stock Exchange, Sanofi-Aventis said that as of 5 p.m. (Eastern) on September 6, a total of approximately 752,392 Aventis ADSs (including 241,429 Aventis ADSs subject to the guaranteed delivery period) had been tendered in and not withdrawn from the U.S. offer during the subsequent offering period.

Based on data provided by Aventis, these tenders represent approximately 25 percent of the approximately 2.9 million Aventis ADSs issued and outstanding as of that date.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE